66780-310 : Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution
| NDC: | 66780-310 |
| Labeler: | Amylin Pharmaceuticals, LLC |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Myalept |
| Dosage Form: | Subcutaneous Injection, Powder, Lyophilized, for Solution |
| Application #: | BLA125390 |
| Rev. Date: |
NDC Package Codes:
- 66780-310-01: 1 VIAL, GLASS IN 1 CARTON (66780‑310‑01) > 2.2 ML IN 1 VIAL, GLASS
Active Ingredients:
- Metreleptin
Dosage Strength:
- 11.3 mg/2.2mL
Pharmaceutical Classes:
- Leptin Analog [EPC]
- Analogs/Derivatives [Chemical/Ingredient]
- Leptin [Chemical/Ingredient]
Related Products:
Based on records with the same trade name.- 10122-210 Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Chiesi USA, Inc.
- 76431-210 Myalept 11.3 mg/2.2ml Subcutaneous Injection, Powder, Lyophilized, for Solution by Aegerion Pharmaceuticals, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 66780-226Next: 66794-010 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.